@article{836ae3608b954679bb36f825ba3a473b,
title = "Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study",
author = "Andrew Blauvelt and Armstrong, {April W.} and Langley, {Richard G.} and Kurt Gebauer and Diamant Tha{\c c}i and Jerry Bagel and Guenther, {Lyn C.} and Carle Paul and Bruce Randazzo and Susan Flavin and Hsu, {Ming Chun} and Yin You and Kristian Reich",
note = "Funding Information: This study was funded by Janssen Research & Development, LLC, Spring House, PA, USA. D. Tha{\c c}i reports personal fees from AbbVie, Almirall, Amgen, Asana Biosciences, Biogen Idec, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Janssen-Cilag, Kyowa Kirin, LEO Pharma, Eli Lilly, Novartis, Regeneron, Sandoz, Sanofi-Aventis, Pfizer, and UCB, grants from AbbVie, Celgene, LEO Pharma, and Novartis. J. Bagel has received research funds payable to Psoriasis Treatment Center from AbbVie, Amgen, Arcutis Biotherapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Celgene Corporation, Corrona LLC, Dermavant Sciences, LTD, Dermira, UCB, Eli Lilly, Glenmark Pharmaceuticals Ltd., Janssen Biotech, Kadmon Corporation, LEO Pharma, Lycera Corp, Menlo Therapueutics, Novartis, Pfizer, Regeneron Pharmaceuticals, Sun Pharma, Taro Pharmaceutical Industries Ltd., and Ortho Dermatologics; consultant fees from AbbVie, Amgen, Celgene Corporation, Bristol Myers Squibb, Eli Lilly, Janssen Biotech, Novartis, Sun Pharmaceutical, and UCB; and speaking fees from AbbVie, Celgene Corporation, Eli Lilly, Janssen Biotech, and Novartis. The authors wish to thank Kristin Ruley Sharples, PhD, of Janssen Scientific Affairs, LLC, Horsham, PA for her writing and editorial support in the preparation of this manuscript. Publisher Copyright: {\textcopyright} 2021 The Author(s). Published with license by Taylor and Francis Group, LLC.",
year = "2022",
doi = "10.1080/09546634.2021.1959504",
language = "English",
volume = "33",
pages = "2317--2324",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Informa Healthcare",
number = "4",
}